Moreover, inhibition of STAT3 phosphorylation by the JAK2 inhibitor WP1066 led to a marked attenuation of skin disease, demonstrating the relevance of this pathway for the development of clinical disease, further demonstrating the overlap in pathogenesis between psoriasis and the current model (figure 6c). The gene discussed is STAT3; the disease is psoriasis.